摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-4-(6-methoxy-7-methyl-3-oxo-4-((2-(trimethylsilyl)ethoxy)-methoxy)-1,3-dihydroisobenzofuran-5-yl)-2-methylbut-2-enal | 1229030-09-4

中文名称
——
中文别名
——
英文名称
(E)-4-(6-methoxy-7-methyl-3-oxo-4-((2-(trimethylsilyl)ethoxy)-methoxy)-1,3-dihydroisobenzofuran-5-yl)-2-methylbut-2-enal
英文别名
(E)-4-[6-methoxy-7-methyl-3-oxo-4-(2-trimethylsilylethoxymethoxy)-1H-2-benzofuran-5-yl]-2-methylbut-2-enal
(E)-4-(6-methoxy-7-methyl-3-oxo-4-((2-(trimethylsilyl)ethoxy)-methoxy)-1,3-dihydroisobenzofuran-5-yl)-2-methylbut-2-enal化学式
CAS
1229030-09-4
化学式
C21H30O6Si
mdl
——
分子量
406.551
InChiKey
AXEXAVIXMJCAFH-VGOFMYFVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.05
  • 重原子数:
    28
  • 可旋转键数:
    10
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    71.1
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-4-(6-methoxy-7-methyl-3-oxo-4-((2-(trimethylsilyl)ethoxy)-methoxy)-1,3-dihydroisobenzofuran-5-yl)-2-methylbut-2-enal 在 sodium tetrahydroborate 、 cerium(III) chloride heptahydrate 、 盐酸 作用下, 以 甲醇乙酸乙酯 为溶剂, 以57%的产率得到(E)-6-(4-hydroxy-3-methylbut-2-en-1-yl)-5-methoxy-4-methyl-7-((2-(trimethylsilyl)ethoxy)methoxy)isobenzofuran-1(3H)-one
    参考文献:
    名称:
    Triazole-Linked Inhibitors of Inosine Monophosphate Dehydrogenase from Human and Mycobacterium tuberculosis
    摘要:
    The modular nature of nicotinamide adenine dinucleotide (NAD)-mimicking inosine monophsophate dehydrogenase (IMPDH) inhibitors has prompted us to investigate novel mycophenolic adenine dinucleotides (MAD) in which 1,2,3-triazole linkers were incorporated as isosteric replacements of the pyrophosphate linker. Synthesis and evaluation of these inhibitors led to identification of low nanomolar inhibitors of human IMPDH and more importantly the first potent inhibitor of IMPDH from Mycobacterium tuberculosis (mtIMPDH). Computational studies of these IMPDH enzymes helped rationalize the observed structure-activity relationships. Additionally, the first cloning, expression, purification and characterization of mtIMPDH is reported.
    DOI:
    10.1021/jm100424m
  • 作为产物:
    描述:
    (E)-4-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-2-methylbut-2-enal2-(三甲基硅烷基)乙氧甲基氯 在 sodium hydroxide 作用下, 以 二氯甲烷 为溶剂, 反应 0.33h, 以88%的产率得到(E)-4-(6-methoxy-7-methyl-3-oxo-4-((2-(trimethylsilyl)ethoxy)-methoxy)-1,3-dihydroisobenzofuran-5-yl)-2-methylbut-2-enal
    参考文献:
    名称:
    Triazole-Linked Inhibitors of Inosine Monophosphate Dehydrogenase from Human and Mycobacterium tuberculosis
    摘要:
    The modular nature of nicotinamide adenine dinucleotide (NAD)-mimicking inosine monophsophate dehydrogenase (IMPDH) inhibitors has prompted us to investigate novel mycophenolic adenine dinucleotides (MAD) in which 1,2,3-triazole linkers were incorporated as isosteric replacements of the pyrophosphate linker. Synthesis and evaluation of these inhibitors led to identification of low nanomolar inhibitors of human IMPDH and more importantly the first potent inhibitor of IMPDH from Mycobacterium tuberculosis (mtIMPDH). Computational studies of these IMPDH enzymes helped rationalize the observed structure-activity relationships. Additionally, the first cloning, expression, purification and characterization of mtIMPDH is reported.
    DOI:
    10.1021/jm100424m
点击查看最新优质反应信息

文献信息

  • Triazole-Linked Inhibitors of Inosine Monophosphate Dehydrogenase from Human and <i>Mycobacterium tuberculosis</i>
    作者:Liqiang Chen、Daniel J. Wilson、Yanli Xu、Courtney C. Aldrich、Krzysztof Felczak、Yuk Y. Sham、Krzysztof W. Pankiewicz
    DOI:10.1021/jm100424m
    日期:2010.6.24
    The modular nature of nicotinamide adenine dinucleotide (NAD)-mimicking inosine monophsophate dehydrogenase (IMPDH) inhibitors has prompted us to investigate novel mycophenolic adenine dinucleotides (MAD) in which 1,2,3-triazole linkers were incorporated as isosteric replacements of the pyrophosphate linker. Synthesis and evaluation of these inhibitors led to identification of low nanomolar inhibitors of human IMPDH and more importantly the first potent inhibitor of IMPDH from Mycobacterium tuberculosis (mtIMPDH). Computational studies of these IMPDH enzymes helped rationalize the observed structure-activity relationships. Additionally, the first cloning, expression, purification and characterization of mtIMPDH is reported.
查看更多